Viemed Healthcare PE Ratio 2018-2025 | VMD
Current and historical p/e ratio for Viemed Healthcare (VMD) from 2018 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Viemed Healthcare PE ratio as of June 19, 2025 is 21.93.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Viemed Healthcare PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-18 | 6.58 | 21.93 | |
| 2025-03-31 | 7.28 | $0.30 | 24.27 |
| 2024-12-31 | 8.02 | $0.28 | 28.64 |
| 2024-09-30 | 7.33 | $0.27 | 27.15 |
| 2024-06-30 | 6.55 | $0.24 | 27.29 |
| 2024-03-31 | 9.43 | $0.26 | 36.27 |
| 2023-12-31 | 7.85 | $0.26 | 30.19 |
| 2023-09-30 | 6.73 | $0.23 | 29.26 |
| 2023-06-30 | 9.78 | $0.19 | 51.47 |
| 2023-03-31 | 9.66 | $0.15 | 64.40 |
| 2022-12-31 | 7.56 | $0.15 | 50.40 |
| 2022-09-30 | 6.00 | $0.19 | 31.58 |
| 2022-06-30 | 5.38 | $0.20 | 26.90 |
| 2022-03-31 | 4.98 | $0.22 | 22.64 |
| 2021-12-31 | 5.22 | $0.22 | 23.73 |
| 2021-09-30 | 5.55 | $0.24 | 23.13 |
| 2021-06-30 | 7.15 | $0.27 | 26.48 |
| 2021-03-31 | 10.12 | $0.71 | 14.25 |
| 2020-12-31 | 7.76 | $0.78 | 9.95 |
| 2020-09-30 | 8.64 | $0.72 | 12.00 |
| 2020-06-30 | 9.60 | $0.72 | 13.33 |
| 2020-03-31 | 4.76 | $0.29 | 16.41 |
| 2019-12-31 | 6.20 | $0.23 | 26.96 |
| 2019-09-30 | 6.92 | $0.25 | 27.68 |
| 2019-06-30 | 6.84 | $0.18 | 37.98 |
| 2019-03-31 | 4.90 | $0.13 | 37.72 |
| 2018-12-31 | 3.80 | $0.08 | 47.50 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED PRODUCTS | $0.260B | $0.224B |
| Viemed Healthcare Inc. is a home medical equipment supplier which provides post-acute respiratory care services through its subsidiaries Sleep Management L.L.C. and Home Sleep Delivered L.L.C. Viemed Healthcare Inc. is based in Lafayette, United States. | |||